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The food safety risk analysis framework of the FAO/WHO is used in the review of veterinary drug and residue regulation in
South Africa to determine possible inefficiencies within this system. Results indicate that a variety of challenges relating to
the processes of risk assessment, management, and communication do exist, although these occur within a fragmented system
of legislation, functions, and structures. Addressing these challenges therefore requires a change to a more collaborative and
integrated system. It is indicated that for such a change, the underlying challenges of inadequate horizontal communication,
poor conceptualization, and awareness of functions of the system are required to be dealt with.
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INTRODUCTION
The use of veterinary drugs in food-producing animals has
yielded many benefits from increased quality of life of animals
and, therefore, production of quality food as well as economic
gains related to fewer losses in livestock rearing (National Re-
search Council, 1999; Morley et. al., 2005). Veterinary drugs
used in food producing animals have, therefore, been useful to
sustain animal food production. However, with the benefits re-
lated to use of veterinary drugs in animals, their use may also be
cause for concern due to effects that the residues of these drugs
could have on consumers.
Concerns regarding veterinary drug residues in foods differ
based on the type or category of drug used in the animal. The
Codex Alimentarius Commission (CAC) lists on their website
11 functional classes of veterinary drugs. However, these can
be combined into the five categories of veterinary drugs, as de-
scribed by the National Research Council of the United States of
America (USA). These include: topical antiseptics, ionophores,
hormone and hormone-like drugs, antiparasitic drugs, and an-
tibiotics or antimicrobials (National Research Council, 1999).
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The first category refers to all drugs used on the surface on the
animal to prevent or combat infection like iodine in solution,
while the second category refers to drugs that alter stomach mi-
croorganisms for enhanced nutrient uptake efficiency like mo-
nensin (also considered an antimicrobial). Antiparasitic drugs
like abamectin are used for treatment of parasites in animals
while hormone/hormone-like drugs are generally used for faster
growth of animals through efficient feed conversion, of which
examples include recombinant bovine somatotrophin (rBST)
and ractopamine. Antibiotics are perhaps the most well known
and are used for treatment against microorganisms that cre-
ate or exacerbate infection. Examples include tetracycline or
gentamycin.
However, of these categories indicated by either the Na-
tional Research Council or the CAC, the two most widely
debated for their use in food animals is antimicrobials and
hormone/hormone-like drugs. Use of antimicrobials in food pro-
ducing animals has sparked the concern of the possible build-up
of resistance of bacteria found in humans because of exposure
to antimicrobials in animal-source foods. This could mean that
treatment methods with similar if not the same antimicrobials
in humans for illness could be rendered less effective. Antimi-
crobial resistance is of concern because antimicrobials are not
only used for therapeutic purposes via dose-controlled admin-
istration to protect animals against pathogenic bacteria, but are
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also used subtherapeutically (when administered through feed)
to increase efficiency in food uptake and utilization in animals
(National Research Council, 1999; Doyle, 2006). Off-label use,
where a specific veterinary drug has not been tested for and used
on different animals and/or changes in dose, has also increased
the concern of build-up of resistance by bacteria in humans (Na-
tional Research Council, 1999; Catry et al., 2003; Doyle, 2006).
A further concern of the use and misuse of antimicrobials as
well as other types of veterinary drugs is exposing susceptible
human populations to increased concentrations of these drugs
thus exacerbating allergic and/or toxic responses (National Re-
search Council, 1999). Antimicrobials can also interfere with
the intestinal microbial balance (Cerniglia and Kotarski, 2005),
which can allow for the overgrowth of exogenous pathogens
(Jeong et. al., 2009) allowing for increased illness related to the
digestive system.
Other veterinary drugs, particularly growth promoting chem-
icals that have corresponding hormones in humans, have also
received much attention as it has been postulated that it could
have effects on humans. The rBST case between the USA and
the European Union (EU) indicates the controversy in the use of
this hormone (Brinckman, 2000; Collier, 2000) whether it is for
effects on humans or animal welfare reasons. Other hormones
like oestrogens are also in the spotlight because studies indicate
that even minute amounts of exogenous oestrogens could po-
tentially alter reproductive ability and development particularly
in young children (Andersson and Skakkebaek, 1999; Partsch
and Sippell, 2001; Aksglaede et. al., 2006). Beyond the risks to
human health, veterinary drug residues in excreta of livestock
may affect ecosystems and have toxicity concerns for specific
organisms in the environment (Yoshimura and Endoh, 2005).
The understanding that residues of veterinary drugs could
be a likely food safety and public health concern prompted the
need for various countries to control the administration of vet-
erinary drugs to food producing animals. Countries developed
a regulatory system of legislation, structures, and function for
controlling veterinary drugs and their residues. In South Africa,
the regulatory system was initiated as far back as 1947 when
veterinary drugs were registered as stock remedies under the
Department of Agriculture (Act 36 of 1947). After this initial
regulation, the control of veterinary drugs and veterinary drug
residues has evolved considerably. The current regulatory sys-
tem is the focus of this paper.
The review of the regulation of veterinary drug residues is
conducted under the framework of food safety risk analysis as
described by FAO/WHO, (2006) although the existing system
was never modeled on this framework. The application of this
framework is for insight into the possible inefficiencies and/or
challenges of the veterinary drug residue regulatory system as
it is a recommended model by the global authorities on food
control systems, the Food and Agricultural Organisation (FAO)
and the World Health Organisation (WHO) (FAO/WHO, 2006).
This review categorizes the legislation, structures, and functions
relevant to the regulation of veterinary drug residues as it occurs
in South Africa based on risk assessment (RA), risk management
(RM), and risk communication (RC) (FAO/WHO, 2006). The
regulatory system is also discussed to define the challenges
that are present and to determine whether and how they can be
addressed.
RISK ANALYSIS AND THE REGULATION
OF VETERINARY DRUG RESIDUES
South Africa’s registration of veterinary drugs is conducted
under two different Acts, the Medicines and Related Substances
Act, 1965 (Act 101 of 1965) and the Fertilizers, Farm Feeds,
Agricultural Remedies and Stock Remedies Act, 1947 (Act 36
of 1947). These two Acts separate drugs for animal use into
veterinary drugs (Act 101 of 1965) and stock remedies (Act 36
of 1947). Because of these two pieces of legislation, risk anal-
ysis functions are conducted for both Acts. Table 1 provides a
summary of the structures, legislation, and functions of the reg-
ulatory system of veterinary drug residues under the categories
of risk assessment, risk management, and risk communication.
The following sections are based on the information provided
in Table 1.
Risk Assessment
Act 101 of 1965 is administered by the Department of Health
(DoH) where risk assessments are conducted by technical sub-
committees of a specialist Council called the Medicines Con-
trol Council (MCC). Specific to veterinary drugs, the Veteri-
nary Clinical Committee (VCC) of the MCC conducts the risk
assessment of all veterinary drugs requesting registration un-
der Act 101 of 1965. In addition, the Biologicals Committee
(BC) conducts risk assessment on biological-based veterinary
medicines like vaccines. The VCC, BC, and MCC are com-
posed of academics as well as government representatives. The
Registrar: Act 101 of 1965 is a senior manager in the DoH,
in the section of Pharmaceutical and Related Product Regula-
tion and Management. The registrar holds the register of drugs
(including veterinary drugs) and heads the secretariat support
to the MCC. Amendments to Act 101 of 1965 in 2008 have
made provision for the South African Health Products Regula-
tory Authority (SAHPRA) which will replace the MCC (The
Medicines and Related Substances Amendment Act, Act 72 of
2008; Chanda et al., 2010). This change was legislated after a
task team compiled recommendations to improve the efficiency
of the registration of medicines under Act 101 of 1965 (DoH,
2008).
The four parts of risk assessment, as described in by
FAO/WHO, (2006), can be identified in existing functions
under Act 101 of 1965. This includes hazard identification
where risk managers do not commission a risk assessment as
the current process allows for the compulsory assessment of
all veterinary drugs (includes food safety assessment). Hazard
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characterization is conducted by the VCC (and BC where appli-
cable) where safety, efficacy, and toxicology are assessed. Food
safety toxicology and exposure assessment is also conducted
at this level as the Directorate: Food Control (representing the
mandate for food safety) is represented at the VCC meetings. Ex-
posure assessments require a food basket for the various tissues
of food producing animals that are consumed as foods. Since
South Africa does not have its own food basket, the international
values based on those utilized by the Joint FAO/WHO Expert
Committee on Food Additives (JECFA) are used in the expo-
sure assessment by the VCC. The resultant maximum residue
limit (MRL), which is recommended for publication under the
Foodstuffs, Cosmetics and Disinfectants Act, 1972, is also de-
termined at this time although there has been lack of capacity
for the calculation and extrapolation for MRLs. Risk charac-
terization, the last of the four components of risk assessment,
is encapsulated in the recommendations that the VCC (and/or
BC) puts forward to the MCC for final decision on a veterinary
drug. The MCC, after final decision (risk management stage),
will route these conclusions back to the Office of the Regis-
trar: Act 101 of 1965 for communication to the applicant. The
risk assessment system under Act 101 of 1965 makes use of a
peer-review system for evaluation of veterinary drugs and its
risk assessments are separated both structurally and function-
ally from those of risk management (Chanda et. al., 2010), a
favored separation to distinguish between science and policy
issues (FAO/WHO, 2006, 49).
The Fertilizers, Farm Feeds, Agricultural Remedies and
Stock Remedies Act, 1947 (Act 36 of 1947) regulates veteri-
nary drugs as stock remedies and was created to provide easy
over-the-counter access to veterinary drugs by farmers. Under
this Act, an applicant needs to register their stock remedy by
submitting an application to the Registrar: Act 36 of 1947 of
the Department of Agriculture, Forestry and Fisheries (DAFF).
Risk assessment is conducted in-house by officials of the office
of the Registrar as well as the DoH, Directorate: Food Control,
either in-house or through expert consultants. In comparison to
processes under Act 101 of 1965, risk assessment and risk man-
agement functions are not separated and assessments under Act
36 of 1947 do not make use of a defined peer-review system
(Chanda et. al, 2010). Therefore, although risk assessments are
conducted by both registration Acts, the process of assessment
under these two Acts is inconsistent.
Similar to risk assessment under Act 101 of 1965, hazard
identification is encapsulated in the process of registration where
all stock remedies applying for registration need to undergo a
risk assessment. Hazard characterization is conducted by offi-
cials of both DAFF and DoH (Directorate: Food Control) where
efficacy, safety, and toxicology assessment are conducted. Ex-
posure assessment is a function of the DoH, Directorate: Food
Control, where food basket values of JECFA are also used to
determine approximate exposure but because of the lack of ca-
pacity to calculate and extrapolate MRLs, this function does not
occur routinely. This is, therefore, also the reason why the risk
management strategy of publication of MRLs has a poor record
of being updated. Risk characterization is conducted by both the
DoH and DAFF, although the process is not distinct as the risk
assessment and risk management processes are not separated.
Risk Management
A variety of risk-management strategies have been identi-
fied, although they may not have been specifically intended for
management of veterinary drug residues. They do, however,
contribute or have the potential to contribute to the control of
veterinary drug residues and are categorized in Table 1. The two
registration Acts as well as Act 54 of 1972 legislate the majority
of risk-management strategies, although specific structures for
risk management strategies are really only evident under Act
101 of 1965 with the MCC as the risk-management body. In
addition, the office of the Registrar: Act 101 of 1965 supports
this risk management body due to its secretariat responsibilities.
For both Act 54 of 1972 and Act 36 of 1947, risk-management
decisions are conducted together with risk assessments. Some
risk-management strategies like extension services and residue
monitoring are not specifically legislated but are conducted by
respective Departments under their overall mandate.
Registration of Veterinary Drugs and Control of Access
The registration of veterinary drugs is probably the first as-
pect of regulation of veterinary drugs and thus regulation of
residues of these drugs. Registration of drugs is also the initial
regulation for the control of animal health, animal production,
and public health concerns (Fingleton, 2004) and is therefore
wider than the public health concern of exposure to veterinary
drug residues via foods. Many countries employ registration of
drugs, including veterinary drugs as a risk-management strat-
egy. These include Zimbabwe under the Medicines and Allied
Substance Control Act, 1969; New Zealand under the Agricul-
tural Compounds and Veterinary Medicines Act, 1997; Taiwan
under the Veterinary Drugs Control Act, 1971; and the United
States of America under the Federal Food, Drugs and Cosmetics
Act, to name a few.
In South Africa, as was indicated previously, both Acts 101
of 1965 and 36 of 1947 are registration authorities with desig-
nated Registrars who administer these Acts. However, for con-
trol of access of veterinary drugs, only Act 101 of 1965 has a
scheduling requirement where drugs are scheduled according to
their safety profile and their access is controlled either over-the-
counter or through prescription from a qualified veterinarian.
Act 36 of 1947 allows over-the-counter access for all registered
stock remedies, which includes antimicrobials. This is prob-
lematic because misuse of antimicrobials in animals elevates
the risk of development of resistance.
Commissioning a Risk Assessment
Since this task is conducted by risk managers (FAO/
WHO, 2006, 37), it is considered a risk-management function.
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However, it has been discussed earlier under risk assessment for
both pieces of legislation that require registration of veterinary
drugs/stock remedies.
Publication of MRLs
One of the most prominent RM strategies, specifically for
veterinary drug residues in food, is the publication of MRLs of
veterinary drug residues in foods of animal origin. This includes
MRLs for meat and organs of animals as well as secondary
products like eggs of fish and poultry, and milk from cattle and
goats. In addition, for veterinary drugs that accumulate in fatty
tissue (fat soluble), an MRL specific to fatty portions of the
animal is also provided. This RM strategy is heavily dependent
on the risk assessment of the veterinary drug for toxicity as
well as the withdrawal period (withholding period) in specific
animals.
Many countries employ this RM strategy, Australia under
standard 1.4.2 of the Food Standards Code; the USA where
MRLs are known as tolerances under the Food, Drug and Cos-
metic Act, 1938; the European Union under the Council Reg-
ulations EEC 2377/90; Japan under the Food Sanitation Law,
1947, and the Positive List of Maximum Residue Limits for
Agricultural and Veterinary Chemicals (brought into effect on
the 29 May 2006); and the Philippines under the Philippine Na-
tional Standard /BAFPS 48:2007 ICS 11.220: Veterinary Drug
Residues in Food: Maximum Residue Limits. Even countries
that don’t specifically publish MRLs of their own, and use
Codex Alimentarius Commission (CAC) standards as references
(CAC/MRL 02/2008) inadvertently utilize this RM strategy as
the CAC standards set MRLs for veterinary drug residues in
foodstuffs. In South Africa, MRLs should be extrapolated from
data after the risk assessment has been conducted under both
registration Acts but MRLs included in Regulations No. R. 1089
of 1992 were also based on limits of the Codex Alimentarius
Commission (CAC). However, Regulation No. R. 1089 of 1992
has only been amended once in 1999 to include new MRLs and
the poor updating of this publication can be attributed to a lack
of capacity in calculating withdrawal periods and extrapolating
for MRLs. The enforcement of published MRLs is delegated
to the provinces and local municipalities of the country and is
addressed in the following section.
Compliance Monitoring
Compliance monitoring involves the requirement to deter-
mine and react to exceeding limits of published MRLs. The
function of compliance monitoring requires specific activities
that are resource-intensive. For example, inspectors are required
for sampling of meat and animal-source foodstuffs, while labo-
ratories are required for the analysis of residues in these food-
stuffs. For sampling, sampling methods, and number of samples
play an important role in sampling validity while, for analysis,
highly qualified personnel and expensive laboratory equipment
and test material are required. In addition, methods of analysis
need to be accredited internationally to have integrity as a re-
liable method (Serratosa et. al., 2006). Other specific activities
like fines for concompliance, destroying noncompliant foods,
and/or prosecuting of the responsible person(s) is also required
for compliance monitoring. Therefore, although the publication
of MRLs does exist in certain countries, the compliance to the
published MRLs is often not policed because of resource con-
straints, constraints in the knowledge and skill of inspectors,
and analysts and poor credibility of state laboratories, if these
laboratories exist.
In South Africa, compliance monitoring related to the publi-
cation of MRLs is inferred because Environmental Health Prac-
titioners (EHPs) of the provinces and districts are authorized
to enforce regulations of the Foodstuffs, Cosmetics and Disin-
fectants Act, 1972, including that of Regulations No. R. 1089
of 1992. In addition, the National Health Act, 2003 (Act 61
of 2003) indicates under its definitions that food control en-
forcement is a responsibility of local municipalities. EHPs of
provinces and local municipalities collect samples and submit
to forensic chemistry laboratories managed by the National De-
partment of Health. In addition, provinces and local authorities
must budget for collecting and courier of samples to laborato-
ries, which adds extra burden on the budget of the particular
Department of the provincial or local authorities.
However, compliance monitoring of veterinary drug MRLs
by the Department of Health (as conducted by Provinces or local
municipalities) is not routinely conducted except for testing of
antimicrobials in honey, a recent requirement (Campbell, 2009,
personal communication), and this could be attributed to, among
other reasons, the lack of analytical testing capability by the
Department of Health laboratories (Campbell, 2009, personal
communication; Tholo, 2009, personal communication).
Other specific activities within this risk management strategy
like issuing of fines, ban, seizure, and destruction of foodstuffs
and/or refusal to allow entry of the foodstuff into the country, if
it is not compliant, are addressed in the Foodstuffs, Cosmetics
and Disinfectants Act, 1972. The Act allows for fining manufac-
turers (with no stipulation of maximum fine) for noncompliant
foodstuffs as well as destruction of the condemned foodstuffs.
Foodstuffs not compliant and presenting at ports of entry are
also refused entry if not compliant or of poor quality. However,
even though these stipulations do exist, since sampling and anal-
yses are rarely conducted, these are not currently applicable for
veterinary drug residues.
Residue Monitoring
Residue monitoring involves the sampling of foodstuffs to
determine trends in use of veterinary drugs and to identify areas
for further and directed monitoring (WHO/FAO, 2009). Residue
monitoring also provides information on whether veterinary
drugs have been used according to the label or whether off-
label use is prevalent in the country. Usually only one, or a few
veterinary drugs are chosen and tested for in meat and meat
products. No enforcement or follow-up actions are typically
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carried out in residue monitoring. The WHO/FAO, (2009) indi-
cates further that monitoring and sampling relating to residues
like directed sampling, special or pilot surveys, and targeted
sampling. These are either for determining trends of residues in
foodstuffs or to investigate in detail the accumulated levels of
residue in a combination of foods after preparation. Sometimes
there is little distinction between residue monitoring and compli-
ance monitoring and the two can be combined. Countries that
have indicated programs include mainly developed countries
like the EC under Directive EC 90/23; Canada through the Na-
tional Chemical Residue Monitoring Programme, or NCRMP;
the USA through the National Residue Program of the Food
Safety and Inspection Service; and New Zealand under the Food
Residues Surveillance Program, where it is less common in de-
veloping countries.
The Department of Agriculture, Forestry and Fisheries
(DAFF) has a National Residue Export Control Programme
which tests for residues of chemicals (including veterinary
drugs) in carcasses intended for export as well as a small, very
limited, residue monitoring program for animal products con-
sumed in South Africa due to financial constraints of analyz-
ing large samples. However, residue monitoring is conducted
by private retail and manufacturing companies, particularly for
substances like antibiotics in milk since antibiotics may hamper
production of cheese and yoghurts that require start up cultures
(Cogan, 1972).
Extension or Outreach Services
Extension or outreach services within the context of vet-
erinary drug and residue regulation is discussed here as an
RM strategy largely because the FAO/WHO, (2003) text in-
dicates that Information, Education, Communication and Train-
ing (IECT) functions should be a part of a food control system
where various stakeholders are informed, educated, and trained
on food-control issues. IECT functions of government, particu-
larly to rural and small-holder farmers of developing countries,
allows for encouragement and/or specific training for the es-
tablishment of animal health-management strategies which are
fundamental for controlled use of veterinary drugs.
Due to the existence of parallel subsistence and commercial
farming in South Africa, the former of which usually exists
as small-holder or rural-based farmers (Gehring et. al., 2002),
awareness is much more important. Subsistence farmers are
typically poor, live in rural areas away from resource centers,
have high levels of illiteracy, and have generally limited ac-
cess to resources for the rearing of their livestock (Gehring et.
al., 2002; Keyyu et. al., 2003; Jones, 2009, personal communi-
cation). Bearing in mind the existence of subsistence farming
together with the understanding of government’s requirements
for enhancing rural or small-holder farmers in South Africa,
outreach, communication, and education is an important RM
strategy for enhancing these farmers’ awareness on animal food
production techniques, use of veterinary drugs, and impact of
residues on human health.
In South Africa, DAFF conducts extension services through
extension officers who typically provide information on ani-
mal production while animal health technicians together with
regional veterinary practitioners provide information and assis-
tance on animal health including use of veterinary drugs. How-
ever, because these outreach services are provided by DAFF,
they are limited to information of agricultural legislation and
techniques and the impact of veterinary drug residues to human
health is not extended to farmers. Outreach activities are also
conducted by the Farm Unit of the National Council of Societies
for the prevention of Cruelty to Animals (NSPCA) (Jones, 2009,
personal communication) with some manufacturing companies
also having outreach programs. Although the Directorate: Food
Control has a designated official for IECT functions, little has
been done on communication and education regarding veteri-
nary drug regulation and residues as compared to IECT material
for general food hygiene and food preparation.
Risk Communication
Risk communication is not specifically legislated under any
one of the three Acts, but aspects of compulsory communi-
cation, for example, between the Medicines Control Council
(MCC) and the applicant, are legislated in Act 101 of 1965.
The Section that administers the Act, called the pharmaceutical
and related product regulation and management, is actually a
communication structure although largely for communication
between applicants and the MCC. Similarly, Act 36 of 1947
legislates communication between applicant and Registrar as
well as other individuals or bodies constituted in terms of the
Act like appeal boards. Communication for other stakeholders,
particularly the public, is however not legislated nor a constant
function under either of these Acts. However, the Department
of Agriculture, Forestry and Fisheries (DAFF) has extension
services which are a part of risk communication although this is
limited to communication to farmers and to communication of
only agriculture-based knowledge and techniques.
Act 54 of 1972 also has no legislated communication re-
quirements and existing communication is limited to provinces
and local authorities who enforce regulations of the Foodstuffs,
Cosmetics and Disinfectants Act, 1972. However, information
on the function and services provided by both registration au-
thorities and Act 54 of 1972 are available on their respective
Departmental websites.
DISCUSSION
The application of the risk analysis framework to the over-
all structural-functional relationship of the veterinary drug and
residue system provides insight into the various challenges of
the system. These include inconsistent risk assessment processes
between the two registration Acts, lack of, or poor compliance
monitoring (due to inability of laboratories to analyze samples),
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limited residue monitoring under the national residue program,
limited extension services, poor updating of MRLs due to hu-
man capacity constraints and non-defined risk communication
strategies, particularly to the public. Although challenges like
the updating of MRLs and analyses capability of the DoH labo-
ratories can be attributed to lack of technical, financial or human
capacity which can be addressed through training and adequate
budget allocations, the majority of challenges can still be ad-
dressed through collaboration and communication to structure
resources for better functioning. The inability to communicate
and collaborate on common issues highlights the results of the
review of the system under the risk-analysis framework which
show the presence of fragmented structures (between DAFF and
DoH), functions (duplicated or similar functions of the DAFF,
DoH and local authorities) and legislation (Acts 36 of 1947, 54
of 1972 and 101 of 1965), a characteristic previously described
for the entire food control system (Chanda et. al., 2010).
Considering the fragmented structure, function, and legis-
lation through which risk assessment, management, and com-
munication occur, collaborative integration will form the basis
for suggestions to address challenges not limited to capacity
constraints.
Risk Assessment
Risk assessments between the VCC, Directorate: Food Con-
trol and Department of Agriculture, Forestry and Fisheries
(DAFF) are rarely collaborative which sometimes results in reg-
istration of the same products under two different registration
Acts. Regarding structures, only the Department of Health has a
defined risk assessment body, the VCC (or BC), to conduct risk
assessment. In both DAFF and the Directorate: Food Control,
there are no defined risk assessment structures, which is ex-
pected, as they are not legislated under Acts 36 of 1947 and 54
of 1972. For risk assessment structures and functions to be car-
ried out efficiently as per guidelines of the FAO/WHO, (2003),
the first step needs to be the legislating or documenting of col-
laborative risk assessment, if they are not combined altogether. It
is suggested that this could be initially legitimized through sign-
ing of memoranda of understanding (MoU), which are currently
utilized agreements in government for specific shared functions.
This would also address the inconsistency in risk assessments
conducted by both DAFF and DoH in terms of peer reviews,
control of access of drugs by scheduling, and separation of both
risk assessment and risk management. For registration and con-
trol of access of veterinary drugs, these too can be made more
collaborative across the two registration Acts so as to streamline
resource-intense functions.
Risk Management
The processes of risk management in terms of both structures
and functions are also fragmented between the two registration
Acts and the Foodstuffs, Cosmetics and Disinfectants Act, 1972
that mandates each Department or section to conduct their own
risk management (RM) functions. These RM strategies are, like
the risk assessments, not collaborative, which means that where
resources could be pooled they are distributed so that they are not
efficiently utilized. For example, inadequate compliance moni-
toring of veterinary drug MRLs by the Department of Health (as
conducted by Provinces or local municipalities) and the limited
residue monitoring for the country conducted by DAFF could
be addressed by pooling sampling and analyses resources (use
of the parastatal laboratory at the Onderstepoort Veterinary In-
stitute (OVI) and utilization of EHPs and agricultural inspectors
for sampling). It is suggested that this too could be done through
memoranda of understanding. In addition, the DoH and DAFF
should obtain information from the many food retailers and
manufacturers of the country that routinely conduct monitoring
on foods, sold or produced. This will provide valuable data re-
quired to determine usage of veterinary drugs and compliance
to published MRLs of foodstuffs.
Pooling of resources, where fragmentation in both structures
and functions exist, can also be conducted in the RM strategy of
extension or outreach services. Since extension services do exist
through DAFF, the Directorate: Food Control should request that
information on the risks of animal production and animal health
techniques to human health also be included in information
material. Therefore, information to farmers would be holistic
with impact of improper use and/or misuse of veterinary drugs
being understood.
Lack of collaboration is also a limiting factor for risk-
management strategies that need to be implemented but are not.
Monitoring for antimicrobial resistance is one of the biggest
concerns regarding use of not only veterinary antimicrobials
but also antimicrobials used in human medicine. Internationally,
this issue has been addressed by the World Health Organisa-
tion (WHO), World Organisation for Animal Health (OIE), and
the Codex Alimentarius Commission (CAC) under the WHO
Global Principles for Containment of Antimicrobial Resistance
in Animals Intended for Food, the OIE International Standards
on Antimicrobial Resistance, and the Codex Code of Practice
to Minimize and Contain Antimicrobial Resistance (CAC/RCP
61-2005). In South Africa, it has only been considered at the
academic level (Nel et. al., 2004). However, antimicrobial resis-
tance monitoring occurs at medical facilities and through private
facilities largely for human medicines. Based on this situation,
a streamlined program between the Departments of Health and
Agriculture, Forestry and Fisheries, together with private sector
units that are already conducting resistance monitoring, should
be initiated to address this RM function.
Risk Communication
As indicated in Table 1, the communication of risk relat-
ing to veterinary drug residues does not occur through formal
channels except from registration authority to the Directorate:
Food Control and vice versa (for record purposes and eventual
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publication of the residue limit in regulations) as well through
publication of MRLs as regulations in the Government Gazette.
However, regulations are scientific and it is not known what
reach the Government Gazette has on the public. In an effort
to pool resources, the Departments of Agriculture, Forestry and
Fisheries and Health as well as other stakeholders like retail-
ers and food manufacturers should collaborate on the develop-
ment and financing of a holistic communication package to the
public and farmers. This consolidates communication material
and reinforces the message of risks related to veterinary drug
residues to the public. To some extent, although not directly
involving the public, collaborative risk communication does oc-
cur between food associations, retailers, the Directorate: Food
Control, and the Department of Agriculture, Forestry and Fish-
eries through meetings of the Food Legislation Advisory Group
(FLAG) hosted by the Department of Health.
CONCLUSION
The variety of challenges in the system of veterinary drug and
residue regulation is linked to the fragmentation of structures,
functions, and legislation, which are prohibitive to communica-
tion and collaboration, essential aspects for a functioning sys-
tem. The presence of inadequate horizontal communication is
indicative of poor awareness and conceptualization of how the
various legislation, structures, and functions for veterinary drug
and residue control function as a system. This is limiting as
without the understanding of shared functions, departments and
sections tend to isolate their functions, which is apparent within
the veterinary drug and residue regulatory system. This in turn
deepens fragmentation and poor communication, which results
in a cycle of poor communication, poor collaboration, and frag-
mentation. Thus, as identified challenges are being considered,
the recommendation is that collaboration should be the basis for
change within the system and this requires that communication,
awareness, and conceptualization of the system are addressed
first.
Therefore, the risk analysis framework has proved an appli-
cable instrument in defining the challenges related to the South
African regulation of veterinary drug residues. It has also as-
sisted in exposing underlying challenges of poor horizontal com-
munication between structures and functions of the system and
poor conceptualization and awareness of the system—highly
relevant issues that may sometimes be too subtle to identify as
fundamental challenges.
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